title: Cell survival kinetics in peripheral blood and bone marrow during total body irradiation for marrow transplantation.
abstract: Cell survival kinetics in both peripheral blood and in bone marrow have been studied over the time course of hyperfractionated total body irradiation (TBI) for bone marrow transplantation. Our unique TBI regimen allows the study of the in vivo radiation effect uncomplicated by prior cyclophosphamide, since this agent is given after TBI in our cytoreduction scheme. Peripheral blood cell concentrations were monitored with conventional laboratory cell counts and differentials. Absolute bone marrow cell concentrations were monitored by measuring cell concentrations in an aspirate sample and correcting for dilution with blood by a cell cycle kinetic method using cytofluorometry. In the entire group of patients, time to engraftment with donor marrow was found to be 16.6 +/- 4.4 days and more rapid when a nucleated donor cell dose of greater than or equal to 4.0 X 10(8) cells/kg was given. For lymphocytes in peripheral blood in patients in remission, the effective D0 ranged from 373 rad in 10 children less than or equal to 10 y old, to 536 rad in the four patients between 11-17 y old, while n = 1.0 in all groups. There was no trend observed according to age. Granulocytes had a much higher effective D0, approximately 1000 rad in vivo. Absolute nucleated cell concentration in marrow dropped slowly initially, due to an increased lymphocyte concentration in marrow during a concurrent drop in lymphocyte concentration in peripheral blood, but eventually fell on the last day of TBI ranging from 7-44% of the initial marrow nucleated cell concentration. Marrow myeloid elements, however, dropped continuously throughout the course of TBI.
mesh_terms: D000293:Adolescent; D000328:Adult; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002470:Cell Survival; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006098:Granulocytes; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D013997:Time Factors; D014916:Whole-Body Irradiation / Q000379:methods*
chemical_list: D003520:Cyclophosphamide